Faruqi and Faruqui, LLP Logo
Share this page

Innocoll Holdings plc (INNL)



Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Innocoll Holdings plc To Contact The Firm Before Lead Plaintiff Deadline

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Innocoll Holdings plc (“Innocoll” or the “Company”) (NASDAQ:INNL) of the March 27, 2017 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the Company and certain officers.

The lawsuit has been filed in the U.S. District Court for the Eastern District of Pennsylvania on behalf of all those who purchased Innocoll publicly traded securities between November 3, 2016 and December 29, 2016 (the “Class Period”).  The case, PEPICELLI v. INNOCOLL HOLDINGS PUBLIC LIMITED COMPANY et al, No. 2:17-cv-00341 was filed on January 24, 2017, and has been assigned to Judge Gene E.K. Pratter.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) Innocoll’s New Drug Application (“NDA”) submission to the Food and Drug Administration (“FDA”) in October 2016 for XARACOLL, a surgically implantable and bioresorbable bupivacaine-collagen matrix, was incomplete; (2) due to the incomplete NDA submission, XARACOLL would not be approved in 2017 as investors were led to believe; and (3) as a result, Innocoll’s statements about its business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.

Specifically, on December 29, 2016, Innocoll disclosed via a press release that the Company received a Refusal to File letter from the FDA for XARACOLL. The press release stated, among other things, that the Company’s NDA submission “was not sufficiently complete to permit a substantive review.”

On this news, Innocoll’s share price fell from $1.77 on December 29, 2016 to a closing price of $0.69 on December 30, 2016—a $1.08 or a 61.02% drop.

Take Action

If you invested in Innocoll common stock between November 3, 2016 and December 29, 2016 and would like to discuss your legal rights, please fill out the form below. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.  Faruqi & Faruqi, LLP also encourages anyone with information regarding Innocoll’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Request Information

Please tell us about yourself by completing the form and we will provide you with additional
information on how to join the Class Action at no cost to you.

  • Case:
    Innocoll Holdings plc (INNL)

* The submission of this form does not create an attorney-client relationship.

Contact Counsel

Richard W. Gonnello
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330


Case Details


  • 01/25/2017

Send Information

If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.